AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Lineage, Inc.
Video analysis: LINE
All videosNo video analysis for this stock yet. Request one from our team.
News: LINE
VALUE LINE, INC. ANNOUNCES FIRST QUARTER EARNINGS
NEW YORK, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Value Line, Inc., (NASDAQ: VALU) reported financial results for the first fiscal quarter ended July 31, 2026.
Lineage Sues Solar-Panel Company, Contractor Over L.A. Warehouse Fire
Plus, Houthi militants expand control near a strategic Red Sea chokepoint, and the Amazon plane crash is putting a spotlight on freight carrier 21 Air.
Lineage Sues Solar-Panel Operator Over L.A. Warehouse Fire
The world's largest cold-storage operator claims negligence caused a massive blaze and is seeking over $1 billion in damages.
Lineage Co-Executive Chairman Marchetti Buys 25,000 Shares
The purchase signals confidence despite the stock price falling over the past 12 months.
Lineage Sues Altus Power and Pearce Services for Ignoring Safety Warnings and Causing Boyle Heights Fire
LOS ANGELES, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Lineage, Inc. (NASDAQ: LINE) today filed a civil lawsuit in Los Angeles Superior Court against Altus Power, Inc., a commercial solar operator, and its contractor Pearce Services LLC, a subsidiary of CBRE Group, alleging that their negligence caused the June 17, 2026, fire that destroyed Lineage's 500,000 square-foot cold storage facility in the Boyle Heights neighborhood in Los Angeles.
Lineage: The Recovery May Be Delayed, But Not Broken
Lineage (LINE) remains a Buy, with valuation offering a strong margin of safety despite near-term macro headwinds and operational volatility. Q2 results beat expectations; AFFO per share fell 6.2% to $0.76, but guidance was raised to $2.80–$3.05 for full year. LINE's technological and operational advantages drive competitiveness, yet higher leverage (net debt/EBITDA at 6.0x) and industry risks require close monitoring.
IMDELLTRA® IN COMBINATION WITH IMFINZI® DEMONSTRATED LANDMARK IMPROVEMENT IN OVERALL SURVIVAL IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
Phase 3 DeLLphi-305 Study Delivered Highly Significant and Clinically Meaningful Overall Survival Benefit Versus Durvalumab Alone Study Also Met Secondary Progression-Free Survival and Objective Response Rate Endpoints THOUSAND OAKS, Calif., Sept. 8, 2026 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced landmark results from the Phase 3 DeLLphi-305 study, which met its primary endpoint at a pre-specified interim analysis, demonstrating a statistically significant and clinically meaningful improvement in overall survival with IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's Imfinzi® (durvalumab) compared to durvalumab alone.
CARNIVAL CRUISE LINE LAUNCHES CARNIVAL REWARDS™
New Program Introduces Flexible Rewards, Status Recognition, Milestone Benefits and More Ways for Guests to Unlock Meaningful Value MIAMI, Sept. 1, 2026 /PRNewswire/ -- Carnival Cruise Line launched Carnival Rewards today, a first-of-its-kind loyalty program in the cruise industry that gives guests more ways to earn rewards, achieve status and be recognized in ways that matter most to them.
Similar companies
-
EastGroup Properties, Inc.
EGP
·
New York Stock Exchange
Compare
-
CubeSmart
CUBE
·
New York Stock Exchange
Compare
-
Rexford Industrial Realty, Inc.
REXR
·
New York Stock Exchange
Compare
-
AGNC Investment Corp.
AGNC
·
NASDAQ
Compare
-
Federal Realty Investment Trust
FRT
·
New York Stock Exchange
Compare
-
First Industrial Realty Trust, Inc.
FR
·
New York Stock Exchange
Compare